JNJ Press releases 13 January 2015 Vedanta Biosciences Announces License Agreement with Janssen and Johnson & Johnson Innovation for Microbiome Read full story
JNJ Press releases 13 January 2015 Janssen and Johnson & Johnson Innovation Announce License Agreement with Vedanta Biosciences for Microbiome Pharmaceutical Candidate for Inflammatory Bowel Disease Read full story
